Business Description
ArcticZymes Technologies ASA
ISIN : NO0010014632
Total Employee Number:
59Description
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Norway, Germany, France, Italy, UK, Other countries in Europe, and Rest of world.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 13.79 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | 1.11 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 18.81 | |||||
Beneish M-Score | -2.91 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.4 | |||||
3-Year EBITDA Growth Rate | -23.6 | |||||
3-Year EPS without NRI Growth Rate | -39.3 | |||||
3-Year FCF Growth Rate | -21.6 | |||||
3-Year Book Growth Rate | 5.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 69.06 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 17.16 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 88.13 | |||||
9-Day RSI | 70.03 | |||||
14-Day RSI | 61.6 | |||||
3-1 Month Momentum % | 5.82 | |||||
6-1 Month Momentum % | -0.48 | |||||
12-1 Month Momentum % | 24.4 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 15.83 | |||||
Quick Ratio | 15.05 | |||||
Cash Ratio | 13.56 | |||||
Days Inventory | 970.69 | |||||
Days Sales Outstanding | 53.86 | |||||
Days Payable | 304.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | -0.08 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 95.08 | |||||
Operating Margin % | 6.65 | |||||
Net Margin % | 11.59 | |||||
EBITDA Margin % | 14.26 | |||||
FCF Margin % | 19.07 | |||||
OCF Margin % | 21.88 | |||||
ROE % | 4.23 | |||||
ROA % | 3.94 | |||||
ROIC % | 6.03 | |||||
3-Year ROIIC % | -78.49 | |||||
ROC (Joel Greenblatt) % | 12.76 | |||||
ROCE % | 2.38 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 75.77 | |||||
Forward PE Ratio | 58.06 | |||||
PE Ratio without NRI | 75.77 | |||||
Shiller PE Ratio | 66.2 | |||||
Price-to-Owner-Earnings | 128.76 | |||||
PS Ratio | 8.97 | |||||
PB Ratio | 2.96 | |||||
Price-to-Tangible-Book | 3.28 | |||||
Price-to-Free-Cash-Flow | 46.14 | |||||
Price-to-Operating-Cash-Flow | 40.2 | |||||
EV-to-EBIT | 92.54 | |||||
EV-to-Forward-EBIT | 57.37 | |||||
EV-to-EBITDA | 43.19 | |||||
EV-to-Forward-EBITDA | 33.9 | |||||
EV-to-Revenue | 6.15 | |||||
EV-to-Forward-Revenue | 5.33 | |||||
EV-to-FCF | 32.95 | |||||
Price-to-GF-Value | 0.88 | |||||
Price-to-Projected-FCF | 2.15 | |||||
Price-to-Median-PS-Value | 0.91 | |||||
Price-to-Graham-Number | 3.32 | |||||
| Price-to-Net-Current-Asset-Value | 3.67 | |||||
| Price-to-Net-Cash | 4.39 | |||||
Earnings Yield (Greenblatt) % | 1.08 | |||||
FCF Yield % | 2.34 | |||||
Forward Rate of Return (Yacktman) % | -17.79 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ArcticZymes Technologies ASA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 121.129 | ||
| EPS (TTM) (kr) | 0.26 | ||
| Beta | 1.56 | ||
| 3-Year Sharpe Ratio | -0.19 | ||
| 3-Year Sortino Ratio | -0.31 | ||
| Volatility % | 67.24 | ||
| 14-Day RSI | 61.6 | ||
| 14-Day ATR (kr) | 0.032353 | ||
| 20-Day SMA (kr) | 20.9 | ||
| 12-1 Month Momentum % | 24.4 | ||
| 52-Week Range (kr) | 16.15 - 31 | ||
| Shares Outstanding (Mil) | 51.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ArcticZymes Technologies ASA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ArcticZymes Technologies ASA Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-05 | In 121 days | ||
| Third quarter earnings results for 2026 | 2026-11-05 | In 121 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-14 | In 38 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 38 days | ||
| General meeting for 2026 | 2026-05-28 12:00 | 20.00 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-07 08:30 | 22.60 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-07 07:00 | 22.60 (+0.00%) | ||
| Annual report for 2025 | 2026-04-30 | 19.93 (+0.00%) | ||
| Capital Markets Day | 2026-03-06 09:00 | 23.50 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-12 10:00 | 22.00 (+0.00%) |
Show
Entries
ArcticZymes Technologies ASA Frequently Asked Questions
What is ArcticZymes Technologies ASA(LTS:0DRV)'s stock price today?
The current price of LTS:0DRV is kr20.90. The 52 week high of LTS:0DRV is kr31.00 and 52 week low is kr16.15.
When is next earnings date of ArcticZymes Technologies ASA(LTS:0DRV)?
The next earnings date of ArcticZymes Technologies ASA(LTS:0DRV) is 2026-08-14.
Does ArcticZymes Technologies ASA(LTS:0DRV) pay dividends? If so, how much?
ArcticZymes Technologies ASA(LTS:0DRV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on ArcticZymes Technologies ASA
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers